Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Completed 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 51Breast 6Gastrointestinal 5Tumor-Agnostic 4Thoracic 4CNS 4Head & Neck 3Gynecologic 2Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Endocrine 1Classical hematology 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 2Brain Neoplasms 2Recurrence 1Neoplasm Metastasis 1Lung Neoplasms 1

Interventions

Carboplatin 510Cisplatin 410Pemetrexed 400Radiotherapy 285Docetaxel 244Paclitaxel 227pembrolizumab 226Gemcitabine 198Drug Therapy 191Bevacizumab 190Erlotinib Hydrochloride 189Radiosurgery 177Nivolumab 168Etoposide 155durvalumab 154osimertinib 126atezolizumab 109Gefitinib 96Blood Specimen Collection 93Magnetic Resonance Spectroscopy 91Vinorelbine 90anlotinib 88Surgical Procedures, Operative 85Ipilimumab 62Immunotherapy 62Surveys and Questionnaires 60sintilimab 59Specimen Handling 59tislelizumab 58Irinotecan 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × cabazitaxel × Thoracic × Clear all
NCT02166658 2018-01-23

CaBaMet

AIO-Studien-gGmbH

Phase 2 Terminated
8 enrolled
BreastCNSThoracic

Brain Neoplasms, Breast Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Recurrence

NCT01438307 2017-05-24

Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer

University of Alabama at Birmingham

Phase 2 Completed
28 enrolled 11 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01852578 2015-09-28

Cabazitaxel in Relapsed and Metastatic NSCLC

Hellenic Oncology Research Group

Phase 2 Completed
46 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01913067 2014-07-24

CRANIAL

Jules Bordet Institute

Phase 2 Withdrawn
BreastCNSThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡